Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM001 vs Gonal-F in Controlled Ovarian Hyperstimulation for IVF
CTR20181723Phase 3Completed
- Sponsor
- Connext
- Start
- Nov 2018
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of LM-001, sponsored by Connext. Started Nov 2018; status: completed.
02
Drugs
LM-001
Beyond the preview
Go deeper on CTR20181723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181723.